Tirzepatide - CAS 2023788-19-2

Tirzepatide (CAT: I018932) is an investigational medication being developed for the treatment of type 2 diabetes mellitus. It is a peptide-based dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide combines the actions of GIP and GLP-1 to stimulate insulin secretion, inhibit glucagon release, and regulate blood sugar levels. By targeting both receptors, tirzepatide has the potential to provide improved glycemic control compared to single-receptor agonists. Clinical trials have shown promising results in terms of glycemic control, body weight reduction, and cardiovascular outcomes.

Catalog Number: I018932

CAS Number: 2023788-19-2

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight:4813.45

Purity: ≥95%

* For research use only. Not for human or veterinary use.


Property

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight4813.45
Purity≥95%